Ardevora Asset Management LLP purchased a new position in shares of Aetna Inc. (NYSE:AET) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 223,300 shares of the company’s stock, valued at approximately $35,507,000. Ardevora Asset Management LLP owned approximately 0.07% of Aetna as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Lloyds Banking Group plc acquired a new position in Aetna during the third quarter worth $106,000. Bruderman Asset Management LLC acquired a new position in Aetna during the second quarter worth $106,000. Moisand Fitzgerald Tamayo LLC acquired a new position in Aetna during the third quarter worth $116,000. Liberty Capital Management Inc. lifted its stake in Aetna by 206.9% during the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after purchasing an additional 629 shares in the last quarter. Finally, Westside Investment Management Inc. lifted its stake in Aetna by 53.5% during the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after purchasing an additional 400 shares in the last quarter. Institutional investors own 90.93% of the company’s stock.
Shares of Aetna Inc. (AET) traded down $1.80 during mid-day trading on Tuesday, hitting $171.22. The company’s stock had a trading volume of 437,223 shares, compared to its average volume of 2,446,281. The stock has a market capitalization of $57,106.63, a price-to-earnings ratio of 17.15, a price-to-earnings-growth ratio of 1.60 and a beta of 0.61. Aetna Inc. has a 12 month low of $116.04 and a 12 month high of $184.98. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The business’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the company posted $2.07 earnings per share. research analysts forecast that Aetna Inc. will post 9.78 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.17%. The ex-dividend date of this dividend was Wednesday, October 11th. Aetna’s payout ratio is 37.04%.
COPYRIGHT VIOLATION NOTICE: This report was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://sportsperspectives.com/2017/11/14/ardevora-asset-management-llp-takes-position-in-aetna-inc-aet.html.
A number of research analysts have commented on the company. Cantor Fitzgerald cut Aetna from an “overweight” rating to a “neutral” rating in a research note on Thursday, October 26th. BMO Capital Markets upped their price target on Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research note on Friday, October 27th. Raymond James Financial, Inc. upgraded Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price target on the stock in a research note on Friday, November 3rd. Piper Jaffray Companies restated a “hold” rating and set a $187.00 price target on shares of Aetna in a research note on Friday, November 3rd. Finally, Jefferies Group LLC upped their price target on Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research note on Wednesday, November 1st. Eleven equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $170.34.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the firm’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.